Recruiting studies: Congenital Nevi

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Phase 2 · 1 location(s) · Kevin Kim, MD · NCT07237100 Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT02775643 Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adu
Phase N/A · 6 location(s) · University Hospital Tuebingen · NCT06680323 Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT00040352 A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
Phase 2 · 5 location(s) · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · NCT05171894 Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Phase N/A · 8 location(s) · Maastricht University Medical Center · NCT05463757 Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309 Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Phase N/A · 1 location(s) · John Kirkwood · NCT06599619 Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06774989 Identification of Biomarkers for Patients with Vascular Anomalies
Phase N/A · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT03001180 Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268 Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT06330350 Pancreas Registry and High Risk Registry
Phase N/A · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT02775461 An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07371663 Precision Medicine for L/GCMN and Melanoma 2
Phase N/A · 3 location(s) · Fundacion Clinic per a la Recerca Biomédica · NCT06605443 Lymphatic Anomalies Registry for the Assessment of Outcome Data
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT02399527 CongenItal Naevus Cohort for Longitudinal Evaluation
NA · 16 location(s) · Nantes University Hospital · NCT06828822 Lipid Infusions to Optimize Nutrition Trial
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06915441 A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Com
Phase 3 · 1 location(s) · Kaken Pharmaceutical · NCT07285005 Registry of Subjects at Risk of Pancreatic Cancer
Phase N/A · 4 location(s) · Associazione Italiana per lo Studio del Pancreas · NCT04095195 BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Phase N/A · 4 location(s) · Region Skane · NCT05446155 Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699 The Cancer of the Pancreas Screening-5 CAPS5)Study
Phase 3 · 9 location(s) · Johns Hopkins University · NCT02000089 Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119 Project: Every Child for Younger Patients With Cancer
Phase N/A · 278 location(s) · Children's Oncology Group · NCT02402244 B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT04897321 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · 34 location(s) · Relay Therapeutics, Inc. · NCT06789913 Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
Phase N/A · 2 location(s) · Fundacion Clinic per a la Recerca Biomédica · NCT06605417 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · 67 location(s) · BioNTech SE · NCT07070232 Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Phase N/A · 1 location(s) · University Children's Hospital, Zurich · NCT02280889

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.